Citation Impact
Citing Papers
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
2019
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus–Induced Cryoglobulinemia Vasculitis
2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
2017
Apheresis to treat systemic vasculitis
2017
Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus–Associated Cryoglobulinemia Treated With Direct-Acting Antivirals
2016
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study
2018
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis
2017
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
2006
Hepatitis C Infection
2017
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Management of Acute and Recurrent Pericarditis
2020
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Hepatitis C Virus Infection and Rheumatic Diseases
2016
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
2015
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
2015
Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis
2016
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia
2018
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Giant Cell Arteritis versus Takayasu Arteritis: An Update
2020
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
2016
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Works of F. Domont being referenced
Ustekinumab for Behçet's disease
2017
Cryoglobulinemia Vasculitis
2015
Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis
2019
Extrahepatic manifestations of chronic hepatitis C virus infection
2015
Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis
2015
Chronic hepatitis C virus infection, a new cardiovascular risk factor?
2016